Promto®
Therapeutic Segment:
Anti-Ulcerant, Gastric acid suppressant
Generic Name:
Rabeprazole sodium
Indication
Tablets
- 20MG
For the treatment of Active duodenal ulcer; Active benign gastric ulcer; Symptomatic Erosive or Ulcerative Gastroesophageal Reflux Disease (GERD); Gastroesophageal Reflux Disease Long-term Management (GERD Maintenance); Zollinger-Ellison Syndrome; For the eradication of Helicobacter pylori in patients with peptic ulcer disease in combination with appropriate antibacterial therapeutic regiments.